Item 8.01. Other Events.

On July 29, 2022, Meridian Bioscience, Inc. issued a press release announcing the re-authorization of its Revogene SARS-CoV-2 assay from the U.S. Food and Drug Administration. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



99.1      Press Release dated July 29, 2022

104     Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses